Figure 3.
Expression of transcription factor ratios in the peripheral blood of HCV-treated subjects (n=24) analysed for differences in IFNL3 genotype. (a) Ratios show a TBX21 (Th1/NK)-dominant effect associated with the IFNL3 responder genotype (rs8099917 TT and rs12979860 CC). (b) Ratio of TBX21/GATA3 (Th1, NK/Th2) showing significant differences for rs8099917 (P=0.017) and for rs12979860 (P=0.038). (c) Ratio of TBX21/RORC (Th1, NK/Th17) showing significant differences for rs8099917 (P=7.4 × 10−3).